{"abortion spontaneous": 2.79, "adverse drug reaction": 2.87, "adverse event": 2.9, "anal abscess": 16.54, "anaphylactic shock": 2.28, "bronchitis": 3.31, "cellulitis": 5.78, "clostridium difficile infection": 5.74, "colitis ulcerative": 20.18, "crohn's disease": 20.05, "cytomegalovirus infection": 3.81, "disseminated tuberculosis": 45.73, "drug hypersensitivity": 5.75, "drug level decreased": 11.31, "exposure during pregnancy": 9.73, "fistula": 14.3, "flushing": 2.52, "foetal exposure during pregnancy": 4.9, "frequent bowel movements": 12.21, "fungal infection": 5.05, "haematochezia": 2.49, "hepatic function abnormal": 2.02, "infusion related reaction": 31.44, "international normalised ratio increased": 3.33, "interstitial lung disease": 5.41, "intestinal obstruction": 4.24, "liver disorder": 2.73, "lupus-like syndrome": 44.45, "lymphoma": 6.75, "off label use": 2.38, "osteoarthritis": 2.17, "pancreatitis acute": 2.05, "pneumocystis jirovecii pneumonia": 13.45, "pneumonia": 3.51, "premature baby": 8.69, "product use issue": 4.49, "psoriasis": 3.87, "pulmonary tuberculosis": 15.49, "rectal haemorrhage": 2.86, "rheumatoid arthritis": 2.76, "sinusitis": 3.06, "staphylococcal infection": 5.22, "therapeutic product effect decreased": 4.53, "therapeutic product effect incomplete": 2.54, "therapeutic response decreased": 5.83, "tuberculosis": 9.73, "urinary tract infection": 2.2, "vasculitis": 3.05, "weight decreased": 2.38, "white blood cell count increased": 2.59}